Exploratory study of comparison between fluorescence diagnosis and pathology of mesothelioma
Not Applicable
- Conditions
- Mesothelioma Benign Asbestos Pleural Effusion
- Registration Number
- JPRN-UMIN000020266
- Lead Sponsor
- Asahikawa Medical University Respiratory Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Cases of pregnancy or lactation 2. Patients with porphyria 3. Patients with chronic hepatitis, chronic renal failure 4. Cases cannot be obtained the consent of the study 5. Cases that have a clear inflammation findings 6. Patients with a history of drug allergy 7. Patients within consent before obtaining four weeks participating in other clinical trials. 8. Cases with inappropriate to join the study decided by the research investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the sensitivity of the mesothelioma detection per biopsy tissue between fluorescence diagnostics and white light diagnosis.
- Secondary Outcome Measures
Name Time Method 1.To compare successful diagnostic rate of mesothelioma between fluorescent diagnosis and historical control with white light diagnosis 2.To examine the pathological tissue in the biopsy specimen of the fluorescent diagnosis 3.To compare the ratio of tumor lesion area per biopsy tissue area between the fluorescence diagnosis and white light diagnosis. 4. To examine pathological findings of benign asbestos pleural effusion example. 5.To examine the safety of the fluorescence diagnosis of mesothelioma using 5-ALA.